ask="3.25"
ask_size="1500"
average_daily_volume="155361"
bid="2.01"
bid_size="100"
book_value="0.74"
change="+0.11"
change_from_200_day_moving_average="0.19"
change_from_50_day_moving_average="0.02"
change_from_52_week_high="-0.98"
change_From_52_week_low="1.38"
change_in_percent="+4.03%"
close="2.84"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.11"
ebitda="-30.33M"
eps_estimate_current_year="-1.14"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.96"
ex_dividend_date="N/A"
float_shares="21613000"
high="2.88"
high_52_weeks="3.82"
last_trade_date="2/1/2017"
last_trade_price="2.84"
last_trade_size="243"
last_trade_time="4:00pm"
low="2.73"
low_52_weeks="1.46"
market_capitalization="96.98M"
moving_average_200_day="2.65"
moving_average_50_day="2.82"
name="Fate Therapeutics
Inc."
notes="N/A"
one_year_target_price="5.83"
open="2.73"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+6.98%"
percent_change_from_50_day_moving_average="+0.61%"
percent_change_from_52_week_high="-25.65%"
percent_change_from_52_week_low="+94.52%"
previous_close="2.73"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.67"
price_per_sales="20.94"
revenue="4.45M"
shares_outstanding="34148000"
short_ratio="3.95"
stock_exchange="NGM"
symbol="FATE"
volume="54821"
weeks_range_52="1.46 - 3.82"
